Research Projects & Grants

College/University

  • The causes of type 1 diabetes, Role: PI, Cambridge Institute for Medical Research, (11/2015 - 11/2016) Status: Completed

Federal

  • Hyperbaric oxygen enhances function of transplanted human islets in type 1 diabetes. Assessment by MRI., Role: Principal Investigator, National Medical Technology Testbed, Inc., (02/2009 - 03/2011) Status: Closed
  • In vivo dynamic imaging of angiogenesis in transplanted islets, Role: Principal Investigator, National Institutes of Health/DHHS, (09/2006 - 07/2010) Status: Closed

For Profit Organization

  • The genetics and neuroendocrinology of short stature international study (GeNeSIS), Role: PI, Eli Lilly & Co., (10/2015 - 10/2016) Status: Completed
  • An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who are Prescribed Norditropin (Human Growth Hormone) Version 5.0, 01/12/10, Role: PI, Novo Nordisk Pharmaceuticals Inc., (09/2015 - 09/2016) Status: Completed
  • Increlex™ (mecasermin [rDNA origin] injection) growth forum database - IGFD registry: A patient registry for monitoring long-term safety and efficacy of Increlex, Role: Investigator, Tercica, Inc., (02/2012 - 02/2013) Status: Completed
  • Pfizer International Growth Study (KIGS): An International, Non-Interventional, Safety, Multi-Center Open Label Study: Genotropin, Role: PI, Pharmacia, (09/2011 - 09/2012) Status: Completed
  • DEFEND2: Durable-response therapy evaluation for early or new onset Type I Diabetes, Role: PI, Tolerx, Inc, (01/2011 - 01/2012) Status: Completed
  • Genentech National Cooperative Growth Study (NCGS) Postmarketing surveillance program for Nutropin Depot, Nutropin AQ, and Protropin, Role: Investigator, Genentech, Inc., (10/2009 - 10/2010) Status: Completed
  • Basal/bolus therapy with insulin aspart (NovoLog) versus regular human insulin (Novolin R) or insulin lispro (Humalog) in combination with NPH: an open-label, randomized, parallel group, multicenter study in children and adolescents with Type I diabetes, Role: PI, Novo Nordisk Pharmaceuticals Inc., (04/2004 - 04/2005) Status: Completed
  • A randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of anastrozole versus placebo for the treatment of gynecomastia in pubaertal boys, Role: Investigator, AstraZeneca LP (USA), (04/2001 - 04/2002) Status: Completed
  • A study of juveniles with diabetes mellitus comparing the Glucowatch automatic glucose biographer with a hemocue photometer over a 15-hour period, Role: PI, Cygnus, Inc., (11/2000 - 11/2001) Status: Completed

Internal

  • Database for patients at the Pediatric Diabetes Center, Role: PI, LLU Dept. of Pediatrics, (07/2021 - 07/2022) Status: Completed
  • Effect of a Gluten-Free Diet on Ameliorating New-Onset Type 1 Diabetes Mellitus in Children and Adolescents, Role: Principal Investigator, LLU Dept. of Pediatrics, (01/2016 - 12/2023) Status: Closed
  • MEND Program effectiveness study: Type I diabetes and chronic kidney disease, Role: Investigator, LLU Dept. of Counseling & Family Sciences, (12/2015 - 12/2016) Status: Completed
  • Continous glucose measurement using the GlucoWatch G2 biographer in infants of diabetic mothers, Role: Investigator, LLU Dept. of Pediatrics, (10/2005 - 10/2006) Status: Completed
  • Pretransplant growth modulation of pancreatic islets, John Mace Pediatric Research Fund, (07/2003 - 06/2015) Status: Closed
  • Genetics of obesity study (G.O.O.S.), Role: PI, LLU Dept. of Pediatrics, Status: Completed

Non-Profit Organization

  • Detection of human beta cell death in type I diabetes by methylation-specific PCR, Role: PI, Juvenile Diabetes Research Foundation, (04/2015 - 04/2016) Status: Completed
  • Detection of Human Beta Cell Death in T1DM by Methylation-Specific PCR, Role: Principal Investigator, City of Hope, (06/2012 - 06/2013) Status: Closed
  • In vivo imaging of revascularization in islet transplantation, Role: Principal Investigator, American Diabetes Association, Inc., (01/2007 - 12/2007) Status: Closed